Mediabistro logo
job logo

Executive Director, Market Access Strategy (Neurology)

Regeneron, Village of Sleepy Hollow, NY, United States


Overview

The Executive Director, Market Access Strategy leads Neurology channel assessment and access strategy development, supporting the commercialization of a novel siRNA C5 inhibitor for Myasthenia Gravis. Focus is on leading access initiatives in the US and above‑brand Market Access Marketing, providing positive leadership and influence with cross‑functional partners to embed market‑access insights into brand strategies and execution. Responsibilities also include providing strategic support and cross‑functional direction to extended market access teams and external partners. The role reports to the Senior Vice President, Global Market Access and requires independent critical thinking with minimal supervision.

Typical Day

  • Lead overall market access strategy for launch readiness and indication expansions; develop strategies and tactics across channels to optimize broad access.
  • Serve as the market access point person for brand leads; attend meetings and take ownership of projects and initiatives.
  • Lead the launch readiness workstream to support the brand strategy, including payer landscape insights, access/channel/contracting strategy recommendations, value‑messaging development, and field‑team tactical material development.
  • Lead annual brand planning, including market‑access strategy recommendations, initiative planning, and budgeting.
  • Lead and develop payer value and communication platforms in coordination with HEOR, marketing, medical teams, etc.
  • Lead tactical material development for all field teams to support the brand strategy.
  • Develop and coordinate training efforts for payer‑facing teams.
  • Serve as the market‑access point person for home‑office cross‑functional teams (e.g., pricing, HEOR) and all field teams, conducting regular touch‑points to discuss ongoing workstreams and future needs.
  • Oversee tracking, initiatives and analytics around clinical pathways and guideline updates.
  • Monitor all market‑access resources available for field teams and review current resource utilization.
  • Develop benchmarks and metrics to assess the impact of key initiatives.
  • Manage the market‑access budget aligned with key responsibilities.
  • Vendor management: oversee relationships and budgets with vendors pertinent to the scope of work.
  • Stay in sync with all laws, regulations and policies governing the conduct of Regeneron activities.

Qualifications

  • Bachelor’s degree and at least 15 years of industry or relevant professional experience (e.g., physician practice, pharma consulting, patient support).
  • Minimum 10 years of Market Access experience.
  • Experience in Rare Disease, Neurology and gMG preferred.
  • Strong understanding of pharmaceutical selling process, market‑access and pricing landscape, and state/federal policy initiatives.
  • Ability to comprehend complex brand strategies and identify market‑access opportunities.
  • Capable of implementing tactical plans while managing multiple projects simultaneously and prioritizing work to meet deadlines.
  • Effective team player with the autonomy to work independently.

Salary Range (annually)

$255,000.00 - $424,900.00

Equal Opportunity Employment

Regeneron is an equal‑opportunity employer and all qualified applicants will receive consideration for employment without regard to race, color, religion or belief, sex, nationality, national or ethnic origin, civil status, age, citizenship status, membership of the Traveller community, sexual orientation, disability, genetic information, familial status, marital or registered civil partnership status, pregnancy or parental status, gender identity, gender reassignment, military or veteran status, or any other protected characteristic in accordance with applicable laws and regulations. The Company will also provide reasonable accommodation for participants with known disabilities or chronic illnesses, unless the accommodation would impose undue hardship on the operation of Regeneron's business.

#J-18808-Ljbffr